Open Access Open Access  Restricted Access Subscription Access

Development and formulation of Peppermint Oil Balm for the Management of Migraine

Prashant Sharma, Sakshi Tyagi

Abstract


Migraine is a common neurological disorder characterized by recurrent episodes of severe headache, often accompanied by nausea, photophobia, and phonophobia, significantly impacting quality of life. Conventional pharmacological therapies, although effective, are frequently associated with adverse effects and limitations in long-term use. This has led to growing interest in alternative and complementary therapies derived from natural products. Peppermint oil, known for its analgesic, anti-inflammatory, and cooling properties, has emerged as a promising candidate for topical migraine management.

The present study focuses on the development and formulation of a peppermint oil-based balm intended for the effective and safe management of migraine symptoms. The formulation process involved selecting suitable excipients to ensure optimal consistency, stability, and skin permeability of the balm. Peppermint oil was incorporated at an appropriate concentration to maximize therapeutic efficacy while minimizing the risk of irritation. The prepared balm was evaluated for various physicochemical parameters, including appearance, homogeneity, spreadability, pH, and stability under different storage conditions.

In addition, the formulation was assessed for its potential analgesic effect through preclinical or user-based evaluations, emphasizing its ability to provide rapid relief from headache when applied topically to the forehead and temples. The cooling sensation produced by menthol, the major active constituent of peppermint oil, plays a key role in alleviating migraine symptoms by improving blood flow and reducing muscle tension.

Overall, the developed peppermint oil balm represents a natural, cost-effective, and patient-friendly approach for migraine management, with potential for further clinical validation and commercialization.


Full Text:

PDF

References


Abdolahi, M., Karimi, E., Sarraf, P., Tafakhori, A., Siri, G., Salehinia, F., . . . Abdollahi, H. (2021). The omega-3 and Nano-curcumin effects on vascular cell adhesion molecule (VCAM) in episodic migraine patients: a randomized clinical trial. BMC Research Notes, 14(1), 283.

Abo-Elghiet, F., Elosaily, H., Hussein, D. K., El-Shiekh, R. A., A’aqoulah, A., Yousef, E. M., . . . El-Dessouki, A. M. (2025). Bridging gaps in migraine management: a comprehensive review of conventional treatments, natural supplements, complementary therapies, and lifestyle modifications. Pharmaceuticals, 18(2), 139.

Agbetou, M., & Adoukonou, T. (2022). Lifestyle modifications for migraine management. Frontiers in neurology, 13, 719467.

Ahmadifard, M., Yarahmadi, S., Ardalan, A., Ebrahimzadeh, F., Bahrami, P., & Sheikhi, E. (2020). The efficacy of topical basil essential oil on relieving migraine headaches: a randomized triple-blind study. Complementary medicine research, 27(5), 310-318.

Al-Hassany, L., Lyons, H. S., Boucherie, D. M., Farham, F., Lange, K. S., Marschollek, K., . . . Torrente, A. (2023). The sense of stopping migraine prophylaxis. The Journal of Headache and Pain, 24(1), 9.

Ali, B., Al-Wabel, N. A., Shams, S., Ahamad, A., Khan, S. A., & Anwar, F. (2015). Essential oils used in aromatherapy: A systemic review. Asian Pacific Journal of Tropical Biomedicine, 5(8), 601-611.

Amiri, P., Kazeminasab, S., Nejadghaderi, S. A., Mohammadinasab, R., Pourfathi, H., Araj-Khodaei, M., . . . Safiri, S. (2022). Migraine: a review on its history, global epidemiology, risk factors, and comorbidities. Frontiers in neurology, 12, 800605.

Andersen, H. H., Gazerani, P., & Arendt-Nielsen, L. (2016). High-concentration L-menthol exhibits counter-irritancy to neurogenic inflammation, thermal and mechanical hyperalgesia caused by trans-cinnamaldehyde. The Journal of Pain, 17(8), 919-929.

Ashina, M., Katsarava, Z., Do, T. P., Buse, D. C., Pozo-Rosich, P., Özge, A., . . . Yu, S. (2021). Migraine: epidemiology and systems of care. The Lancet, 397(10283), 1485-1495.

Ashina, S., Terwindt, G. M., Steiner, T. J., Lee, M. J., Porreca, F., Tassorelli, C., . . . Lipton, R. B. (2023). Medication overuse headache. Nature Reviews Disease Primers, 9(1), 5.


Refbacks

  • There are currently no refbacks.